On Wednesday, Canaccord Genuity adjusted its price target on shares of Core Scientific Inc. (NASDAQ: CORZ) shares, increasing it to $17.00 from the previous $16.00 while maintaining a Buy rating.
BofA raised the firm’s price target on Boston Scientific (BSX) to $100 from $90 and keeps a Buy rating on the shares. The firm, which sees Boston Scientific having “best in medtech growth ...
Target said it is planning to cut prices of a number of everyday items ahead of the key holiday period. The Minneapolis retailer on Tuesday said it plans to reduce the prices of about 2,000 items ...
Target (TGT) said on Tuesday that it’s kicking off the holiday season by slashing prices on over 2,000 items across its own and national brands. Shoppers can expect to find lower prices on food ...
BTIG raised the firm’s price target on Boston Scientific (BSX) to $97 from $93 and keeps a Buy rating on the shares. The firm notes that while expectations were running high for Boston ...
TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $100 from $86 and keeps a Buy rating on the shares. The firm believes they will beat the Street’s 3Q estimates and once ...